Pascal Soriot celebrates a decade in charge of the FTSE 100 pharmaceuticals group this year. His turnaround of the business, and conviction in the potential of its pipeline, have won the company friends among the fund management world’s cognoscenti.
Fund Managers
Searching for the next Amazon? Try niche stocks with low profits
The biggest technological disruptors – and investment winners – initially generate small margins from niche markets and are ignored by the big players until it’s too late.